Check Your Claims Before Reviewers Do

Evidence summary (what the available papers show)

• Focus and domain: experimental cell biology around autophagy, vacuole formation and broader computational genomics (bifunctional gene annotation) as evidenced by a 2023 experimental preprint and a comprehensive 2026 genome-wide reannotation paper with public code/data (Kinase inhibitor/autophagy preprint, Bifunctional genes genome-wide study).
• Data & reproducibility: the 2026 study provides public code, a Shiny database and source data for major figures — strong reproducibility practice for computational genomics (Data and code availability for bifunctional gene study).
• Experimental validation: RT-qPCR across six human cell lines and cell‑type specific expression analyses were used to support expression of noncoding isoforms for selected genes, but large-scale functional validation is limited (RT-qPCR validation and limitations).

Strengths (evidence-backed)

1. Combines computational breadth and wet‑lab validation: genome-wide annotation paired with targeted RT-qPCR increases credibility of detected bifunctional loci (Combined computational and experimental validation).
2. Open science practices: code repository and a Shiny app enable reproducibility and community re-use (Open code and Shiny app).
3. Topical coherence: author contributions to both an experimental autophagy/vacuole paper and a genome-scale annotation show range — from mechanistic cell biology to genome informatics (Experimental autophagy preprint).

Limitations & blindspots (evidence-backed)

• Small corpus and low citation footprint so far: publicly available metadata shows three works and a small citation count (early career / emerging researcher profile), meaning community validation is limited (Recent high-quality paper with low citation age).
• Functional validation gap: large-scale ORF predictions (~125k ORFs) and miRNA target predictions are hypothesis-generating; most predicted microproteins and ceRNA functions need orthogonal experimental confirmation (ribosome profiling, mass spec, loss-of-function assays) (ORF predictions and need for experimental validation).
• Annotation-dependent biases: reliance on existing transcript catalogs, circRNA databases and orthology mappings can over- or under-estimate bifunctional loci, as the authors note (Study limitations on annotation bias).

Practical takeaways for readers and collaborators

1. Janki Insan is an emerging researcher bridging experimental cell biology and computational genomics; current outputs show strong computational reproducibility practices and focused experimental validation (selected RT-qPCR studies) (Experimental preprint evidence, Computational plus RT-qPCR validation).
2. Next-step experiments to strengthen claims: ribosome profiling (Ribo-seq) and targeted mass spectrometry for predicted microproteins, CRISPR perturbations for candidate bifunctional loci, and cross-species functional assays to confirm conservation hypotheses would materially raise evidence strength.

What would disprove / materially weaken the conclusions?

If high-quality ribosome profiling + targeted proteomics across tissues failed to detect translation of predicted microprotein ORFs at appreciable levels, or if better transcript atlases collapsed many predicted noncoding isoforms into low‑confidence artefacts, then reported bifunctional gene counts and functional interpretations would be substantially weakened (Falsification criteria described by authors).

Direct actionable resources

Interactive database and code:

• Bifunctional Genes Database (Shiny) — browse gene lists and annotations (Bifunctional Genes Shiny app).
• GitHub: analysis scripts — reproducible pipelines and data used to build the annotation (GitHub code for analyses).

Final evidence-weighted judgement

Janki Insan’s work is evidence-forward and reproducible in computational genomics with a complementary experimental skillset; the 2026 genome‑wide study is methodologically thorough and openly shared (strong practices). However, the corpus is small and major functional claims about thousands of bifunctional loci remain hypothesis-generating until broader proteomic and perturbation-based validations are completed (Study scope and limits).